人福医药：二甲磺酸利右苯丙胺胶囊上市许可申请获受理

Group 1 - The core point of the article is that Yichang Renfu, a subsidiary of Renfu Pharmaceutical, has received approval from the National Medical Products Administration for the marketing authorization of Dexmethylphenidate hydrochloride capsules, which are used to treat ADHD and moderate to severe binge eating disorder [1] - Dexmethylphenidate hydrochloride capsules were first approved in the United States and are currently not available in the domestic market, with no related products approved for import [1]